ASX:RHY
Rhythm Biosciences Limited Stock Company Profile
$0.0660
-0.0010 (-1.49%)
At Close: Jun 14, 2024
Information
Bio21 Molecular Science & Biotechnology, 30 Flemington Road
Parkville VIC 3010
www.rhythmbio.com
Industry: Diagnostics & Research
Sector: Healthcare
Description
Rhythm Biosciences Limited, a transformative diagnostics company, engages in developing and commercializing of medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is based in Parkville, Australia.
